FierceBiotech names Brii Biosciences as one of its “Fierce 15” Biotech Companies of 2018

Beijing, China – October 2, 2018 – Brii Biosciences today was named by FierceBiotech as one of 2018’s Fierce 15 biotechnology companies, designating it as one of the most promising private biotechnology companies in the industry.   Brii Biosciences was … Read More

Featured Post

Brii Biosciences Launches to Bring Innovative Medicines to Chinese Patients

Committed funding of $260M includes ARCH Venture Partners, 6 Dimensions Capital, Boyu Capital, Yunfeng Capital, Sequoia Capital, and Blue Pool Capital Exclusive agreement with Vir Biotechnology, Inc. grants greater China rights for up to four infectious disease assets Partnership with … Read More

Featured Post